COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,556 Articles (22,400 medRxiv, 8,156 bioRxiv)

Most recent first Previous |  Page 2004: Articles 20031-20040  | Next

Mental Health Status of Adolescents During the COVID-19 Pandemic: A Cross-sectional Survey among the Bangladeshi Graduate Students at Dhaka City
Husain, T., Chowdhury, S. A., Uddin, M. M., Kalimullah, N. A., 4
10.1101/2020.11.12.379487 — Posted: 2020-11-12
ORF3a mediated-incomplete autophagy facilitates SARS-CoV-2 replication
Qu, Y., Wang, X., Zhu, Y., Wang, Y., Yang, X., Hu, G., Liu, C., Li, J., Ren, S., Xiao, Z., Liu, Z., Wang, W., Li, P., Zhang, R., Liang, Q.
10.1101/2020.11.12.380709 — Posted: 2020-11-12
A practical PPE decontamination method using warm air and ambient humidity
Kwiek, J. J., Pickett, C. R., Flanigan, C. A., Lee, M. V., Saif, L. J., Jahnes, J., Blonder, G.
10.1101/2020.11.12.380196 — Posted: 2020-11-12 Discussion: Onsite | Offsite
Stenoparib, an inhibitor of cellular poly (ADP-ribose) polymerase (PARP), blocks replication of the SARS-CoV-2 human coronavirus in vitro.
French, C. T.
10.1101/2020.11.12.380394 — Posted: 2020-11-12
Goblet Cell Hyperplasia Increases SARS-CoV-2 Infection in COPD
Mehedi, M., Osan, J. K., Talukdar, S. N., Feldmann, F., DeMontigny, B. A., Jerome, K., Bailey, K. L., Feldmann, H.
10.1101/2020.11.11.379099 — Posted: 2020-11-12
Massive X-ray screening reveals two allosteric drug binding sites of SARS-CoV-2 main protease
Guenther, S., Reinke, P. Y. A., Fernandez-Garcia, Y., Lieske, J., Lane, T. J., Ginn, H., Koua, F., Ehrt, C., Ewert, W., Oberthuer, D., Yefanov, O., Meier, S., Lorenzen, K., Krichel, B., Kopicki, J., Gelisio, L., Brehm, W., Dunkel, I., Seychell, B., Gieseler, H., Norton-Baker, B., Escudero-Perez, B., Domaracky, M., Saouane, S., Tolstikova, A., White, T., Haenle, A., Groessler, M., Fleckenstein, H., Trost, F., Galchenkova, M., Gevorkov, Y., Li, C., Awel, S., Peck, A., Barthelmess, M., Schluenzen, F., Lourdu, X. P., Werner, N., Andaleeb, H., Ullah, N., Falke, S., Srinivasan, V., Franca, B., Schwinzer, M., Brognaro, H., Rogers, C., Melo, D., Doyle, J. J., Knoska, J., Pena Murillo, G. E., Rahmani Mashhour, A., Guicking, F., Hennicke, V., Fischer, P., Hakanpaeae, J., Meyer, J., Gribbon, P., Ellinger, B., Kuzikov, M., Wolf, M., Borenkov, G., von Stetten, D., Pompidor, G., Bento, I., Panneerselvam, S., Karpics, I., Schneider, T. R., Garcia Alai, M., Niebling, S., Guenther, C., Schmidt, C., Schubert, R., Han, H., Boger, J., Monteiro, D., Zhang, L., Sun, X., Pletzer-Zelgert, J., Wollenhaupt, J., Feiler, C., Weiss, M. S., Schulz, E. C., Mehrabi, P., karnicar, k., Usenik, A., loboda, j., Tidow, H., chari, A., Hilgenfeld, R., Uetrecht, C., Cox, R., Zaliani, A., Beck, T., Rarey, M., Guenther, S., Turk, D., Hinrichs, W., Chapman, H. N., Pearson, A. R., Betzel, C., Meents, A.
10.1101/2020.11.12.378422 — Posted: 2020-11-12
Bifurcations and mutation hot-spots in the SARS-CoV-2 spike protein
Niemi, A. J., Peng, X.
10.1101/2020.11.11.378828 — Posted: 2020-11-12
Identifying and prioritizing potential human-infecting viruses from their genome sequences
Mollentze, N., Babayan, S., Streicker, D.
10.1101/2020.11.12.379917 — Posted: 2020-11-12
Nanodroplet-Benzalkonium Chloride Formulation Demonstrates In Vitro and Ex Vivo Broad-Spectrum Antiviral Activity Against SARS-CoV-2 and Other Enveloped Viruses
Pannu, J., Ciotti, S., Ganesan, S., Arida, G., Costley, C., Fattom, A. I.
10.1101/2020.11.12.377598 — Posted: 2020-11-12
Neuraminidase inhibitors rewire neutrophil function in murine sepsis and COVID-19 patient cells
Formiga, R. O., Amaral, F. C., Souza, C. F., Mendes, D. A. G. B., Wanderley, C. W. S., Lorenzini, C. B., Santos, A. A., Antonia, J., Faria, L. F., Natale, C. C., Paula, N. M., Silva, P. C. S., Fonseca, F. R., Aires, L., Heck, N., Barroso, S. P. C., Morrot, A., Sordi, R., Alisson-Silva, F., Mansur, D. S., Cunha, F. Q., Maurici, R., Bafica, A., Macauley, M. S., Spiller, F.
10.1101/2020.11.12.379115 — Posted: 2020-11-12

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).